Efalizumab (brand name Raptiva, Genentech, Merck Serono) is a formerly available medication designed to treat autoimmune diseases, originally marketed...
7 KB (367 words) - 19:53, 20 December 2023
adverse effects. Two medications that target T cells are efalizumab and alefacept. Efalizumab is a monoclonal antibody that specifically targets the CD11a...
116 KB (12,973 words) - 02:21, 16 August 2024
for the improvement of pulmonary function in cystic fibrosis. Raptiva (efalizumab), for psoriasis, later withdrawn in 2009 due to the risk of PML. Recormon...
56 KB (5,124 words) - 17:16, 10 August 2024
needed] The boxed warning was added on February 19, 2009, for the drug efalizumab (Raptiva) includes a statement that Human polyomavirus 2, resulting in...
22 KB (2,697 words) - 21:12, 17 August 2024
nails Calcipotriol Calcipotriol plus betamethasone dipropionate ointment. Efalizumab Infliximab Golimumab Low dose methotrexate Intralesional corticosteroid...
14 KB (1,415 words) - 21:23, 27 November 2023
cellular adhesion and costimulatory signaling. It is the target of the drug efalizumab. ITGAL gene encodes the integrin alpha L chain. Integrins are heterodimeric...
10 KB (1,239 words) - 08:31, 10 June 2024
Stefanaki I, Stratigos A, et al. (April 2007). "The Greek experience with efalizumab in psoriasis from a university dermatologic hospital". Br J Dermatol....
16 KB (1,749 words) - 15:25, 5 November 2023
Subcutaneous injection for moderate to severe persistent asthma. 2003: Raptiva (efalizumab): Antibody designed to block the activation and reactivation of T cells...
32 KB (2,862 words) - 04:08, 6 August 2024
Phenazopyridine Monoclonal antibodies such as Infliximab, Adalimumab, Etanercept, Efalizumab, Cetuximab, and OKT3 antibodies. Chemotherapeutic drugs such as Pemetrexed...
7 KB (766 words) - 19:16, 11 February 2023
PML can still occur in people on immunosuppressive therapy, such as efalizumab, belatacept, and various transplant drugs, which are meant to weaken the...
23 KB (2,414 words) - 19:20, 9 February 2024
as shown by PROWESS-SHOCK study Ebrotidine 1998 Spain Hepatotoxicity. Efalizumab (Raptiva) 2009 Germany Withdrawn because of increased risk of progressive...
45 KB (1,903 words) - 22:46, 13 August 2024
Otelixizumab Teplizumab Visilizumab CD4 Clenoliximab Keliximab Zanolimumab CD11a Efalizumab CD18 Erlizumab CD20 Obinutuzumab Ocrelizumab Pascolizumab Rituximab Ublituximab...
7 KB (299 words) - 13:45, 27 April 2024
L04AF07 Deucravacitinib L04AF08 Ritlecitinib L04AG01 Muromonab-CD3 L04AG02 Efalizumab L04AG03 Natalizumab L04AG04 Belimumab L04AG05 Vedolizumab L04AG06 Alemtuzumab...
3 KB (367 words) - 15:37, 25 January 2024
Gram-negative bacteria Edrecolomab Panorex mab mouse EpCAM colorectal carcinoma Efalizumab Raptiva mab humanized LFA-1 (CD11a) psoriasis (blocks T-cell migration)...
136 KB (4,020 words) - 07:14, 15 August 2024
Camrelizumab† Cedelizumab Certolizumab pegol Crizanlizumab Daclizumab Eculizumab Efalizumab‡ Epratuzumab Erlizumab Etrolizumab† Fontolizumab Frexalimab† Inebilizumab...
38 KB (4,304 words) - 10:14, 21 July 2024
contrast material), and the sudden cessation of medication. Methotrexate, efalizumab, and topical and oral steroids are common antipsoriatic drugs that can...
22 KB (2,022 words) - 04:15, 7 August 2024
Otelixizumab Teplizumab Visilizumab CD4 Clenoliximab Keliximab Zanolimumab CD11a Efalizumab CD18 Erlizumab CD20 Obinutuzumab Ocrelizumab Pascolizumab Rituximab Ublituximab...
38 KB (2,656 words) - 12:11, 30 October 2023
(USAN) edrecolomab (INN) edrophonium chloride (INN) Edrophonium Edurant efalizumab (USAN) efaproxiral (USAN) efaroxan (INN) efavirenz (INN) efbemalenograstim...
8 KB (454 words) - 23:25, 20 June 2024
fibrosis (CF) Genentech $257 $223 $199 $186.5 $157.1 $143.7 $138.1 $123 efalizumab Raptiva Plaque psoriasis Genentech $108 $107 $90 $79.2 $52.4 $1.4 montelukast...
12 KB (229 words) - 02:08, 9 December 2023
Malykh, Y.; Philipsen, L.; Gollnick, H. (2007). "The CD11a Binding Site of Efalizumab in Psoriatic Skin Tissue as Analyzed by Multi-Epitope Ligand Cartography...
27 KB (3,023 words) - 10:50, 22 June 2024
Camrelizumab† Cedelizumab Certolizumab pegol Crizanlizumab Daclizumab Eculizumab Efalizumab‡ Epratuzumab Erlizumab Etrolizumab† Fontolizumab Frexalimab† Inebilizumab...
2 KB (87 words) - 01:28, 30 May 2023